Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$43.2M |
| 2 |
Booking.com
BKNG
|
+$32.2M |
| 3 |
RTX Corp
RTX
|
+$32.1M |
| 4 |
Pfizer
PFE
|
+$30.2M |
| 5 |
Northrop Grumman
NOC
|
+$25.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.3M |
| 2 |
IBM
IBM
|
+$43.1M |
| 3 |
Lowe's Companies
LOW
|
+$36M |
| 4 |
Linde
LIN
|
+$29.1M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$27.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 21.23% |
| 2 | Technology | 15.76% |
| 3 | Healthcare | 12.99% |
| 4 | Consumer Discretionary | 12.18% |
| 5 | Consumer Staples | 10.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Supernus Pharmaceuticals
SUPN
$2.62B
| $1.96M | 0.04% |
82,447
-21,103
| -20% | -$513K |
|
|
VRNT
477
DELISTED
Verint Systems
VRNT
| $1.95M | 0.04% |
69,235
-137,275
| -66% | -$3.34M |
|
478
Amdocs
DOX
$6.48B
| $1.95M | 0.04% |
27,027
-40,373
| -60% | -$2.75M |
|
479
Teladoc Health
TDOC
$1.11B
| $1.93M | 0.04% |
23,095
+3,409
| +17% | +$259K |
|
480
Eagle Materials
EXP
$6.15B
| $1.93M | 0.04% |
21,313
-52,002
| -71% | -$4.76M |
|
|
VRS
481
DELISTED
Verso Corporation
VRS
| $1.91M | 0.04% |
106,039
-23,599
| -18% | -$379K |
|
482
T-Mobile US
TMUS
$195B
| $1.91M | 0.04% |
24,323
-17,280
| -42% | -$1.36M |
|
|
SCS
483
DELISTED
Steelcase
SCS
| $1.9M | 0.03% |
92,951
+76,823
| +476% | +$1.42M |
|
|
NLSN
484
DELISTED
Nielsen Holdings plc
NLSN
| $1.87M | 0.03% |
+92,008
| New | +$1.87M |
|
485
Exelixis
EXEL
$13.9B
| $1.87M | 0.03% |
105,901
-462,929
| -81% | -$7.85M |
|
486
Truist Financial
TFC
$61.5B
| $1.86M | 0.03% |
33,067
+2,785
| +9% | +$151K |
|
487
Crane NXT
CXT
$2.88B
| $1.85M | 0.03% |
61,645
-48,989
| -44% | -$1.39M |
|
|
QEP
488
DELISTED
QEP RESOURCES, INC.
QEP
| $1.85M | 0.03% |
411,019
+137,415
| +50% | +$479K |
|
489
Public Storage
PSA
$60.2B
| $1.83M | 0.03% |
8,584
-273
| -3% | -$60.6K |
|
490
Enanta Pharmaceuticals
ENTA
$419M
| $1.82M | 0.03% |
29,479
-11,091
| -27% | -$688K |
|
491
Children's Place
PLCE
$58.5M
| $1.81M | 0.03% |
+28,934
| New | +$2.11M |
|
492
Schneider National
SNDR
$6.1B
| $1.81M | 0.03% |
82,768
+1,194
| +1% | +$26.9K |
|
493
DNOW Inc
DNOW
$2.83B
| $1.79M | 0.03% |
159,546
+47,877
| +43% | +$534K |
|
494
Caesars Entertainment
CZR
$6.05B
| $1.77M | 0.03% |
29,722
+16,586
| +126% | +$821K |
|
|
ECHO
495
DELISTED
Echo Global Logistics, Inc.
ECHO
| $1.77M | 0.03% |
85,641
-35,299
| -29% | -$737K |
|
496
Edgewell Personal Care
EPC
$1.31B
| $1.77M | 0.03% |
57,212
-19,745
| -26% | -$637K |
|
497
Marriott International
MAR
$93.7B
| $1.76M | 0.03% |
11,648
-30,636
| -72% | -$4.1M |
|
498
Unifirst Corp
UNF
$5.24B
| $1.76M | 0.03% |
8,722
-10,764
| -55% | -$2.18M |
|
|
EFOR
499
Everforth Inc
EFOR
$1.3B
| $1.73M | 0.03% |
24,414
-6,184
| -20% | -$404K |
|
500
Cactus
WHD
$5.43B
| $1.73M | 0.03% |
50,325
+23,454
| +87% | +$712K |
|
Similar funds
Joel Greenblatt's Q4 2019 Portfolio in Review
As of Q4 2019, Joel Greenblatt held 1,290 positions worth $5.45B, down 3.8% from $5.66B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Joel Greenblatt withdrew a net $632M in Q4 2019, closing 203 positions and reducing 508 holdings. Its most notable exit was Celgene Corp, an estimated $55.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Joel Greenblatt opened a new position in Phillips 66 worth $42.8M.
- Joel Greenblatt's largest Q4 2019 buy was Phillips 66: 384,100 shares worth $42.8M.
- Joel Greenblatt added most to Booking.com in Q4 2019, an estimated $32.2M increase.
- Joel Greenblatt's biggest Q4 2019 reduction was IBM, cutting an estimated $43.1M.
- Joel Greenblatt fully exited Celgene Corp in Q4 2019, selling an estimated $55.3M.
- Joel Greenblatt's ten largest holdings make up 11% of its $5.45B portfolio in Q4 2019.
- Joel Greenblatt opened 215 new positions and closed 203 in Q4 2019.
- Joel Greenblatt's portfolio value fell 3.8% quarter-over-quarter to $5.45B.
Based on Gotham Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.